Company: BIAF
Filing Date: 2025-04-11
Form Type: S-1
Source: 0001641172-25-003892
Chunk: 209

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-11
Form: S-1
Chunk 209
---
2024, at the reduced exercise price of $0.58 per share (reduced from the initial exercise price of $1.50 per share); and (ii) warrants to purchase up to 87,785 shares of Common Stock to designees of the financial advisor for such warrant inducement, which were immediately exercisable, an exercise price of $0.85 per share, for a term of five years from the date of issuance.

Item 16. Exhibits and Financial Statement Schedules

(a) Exhibits

See the Exhibit Index immediately preceding the signature page hereto for a list of exhibits filed as part of this registration statement on Form S-1, which Exhibit Index is incorporated herein by reference.

(b) Financial Statement Schedules

Schedules not listed have been omitted because the information required to be set forth therein is not applicable, not material or is shown in the financial statements or notes thereto.

Item 17. Undertakings

The undersigned registrant hereby undertakes:

| (1) | To                                                                                                                          
 file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| i.   | to                                                                                                                                     
 include any prospectus required by Section 10(a)(3) of the Securities Act;                                                             |
| ii.  | to                                                                                                                                     
 reflect in the prospectus any acts or events arising after the effective date of this registration statement (or the most recent       
 post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set       
 forth in this registration statement (notwithstanding the foregoing, any increase or decrease in volume of securities offered (if      
 the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end    
 of the estimated maximum offering range may be reflected in the form of a prospectus filed with the Commission pursuant to Rule 424(b) 
 under the Securities Act if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum      
 aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement);            
 and                                                                                                                                    |
| iii. | to                                                                                                                                     
 include any material information with respect to the plan of distribution not previously disclosed in this registration statement      
 or any material change to such information in this registration statement; provided, however, that subparagraphs (i), (ii) and (iii)   
 do not apply if the information